Correlation Between Pfizer and Orogen Royalties

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Orogen Royalties at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Orogen Royalties into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Orogen Royalties, you can compare the effects of market volatilities on Pfizer and Orogen Royalties and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Orogen Royalties. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Orogen Royalties.

Diversification Opportunities for Pfizer and Orogen Royalties

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pfizer and Orogen is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Orogen Royalties in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orogen Royalties and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Orogen Royalties. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orogen Royalties has no effect on the direction of Pfizer i.e., Pfizer and Orogen Royalties go up and down completely randomly.

Pair Corralation between Pfizer and Orogen Royalties

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Orogen Royalties. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 2.42 times less risky than Orogen Royalties. The stock trades about -0.16 of its potential returns per unit of risk. The Orogen Royalties is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  105.00  in Orogen Royalties on September 1, 2024 and sell it today you would lose (1.00) from holding Orogen Royalties or give up 0.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Orogen Royalties

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Orogen Royalties 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orogen Royalties has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pfizer and Orogen Royalties Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Orogen Royalties

The main advantage of trading using opposite Pfizer and Orogen Royalties positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Orogen Royalties can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orogen Royalties will offset losses from the drop in Orogen Royalties' long position.
The idea behind Pfizer Inc and Orogen Royalties pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules